CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The acquisition will leverage the companies’ complementary services—NeoGenomics’ comprehensive test offering, broad portfolio of managed care and GPO contracts, and national laboratory infrastructure and Genoptix’s customized consults and reports and experience serving community oncologists. “With deep relationships across all customer segments, NeoGenomics is positioned to better coordinate oncology testing between oncologists and pathologists within the community to improve patient care,” the company said.
Pages: 1 2